Follicular Lymphoma Grade 3A
5 clinical trials · Condition
◉ Watch Follicular Lymphoma Grade 3A
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma (NCT05326243) | Pell Bio-Med Technology Co., Ltd. | 2022-05-31 |
| "MIRO" Molecularly Oriented Immuno-radio-therapy (NCT02710643) | Fondazione Italiana Linfomi - ETS | 2014-10-01 |
Track Follicular Lymphoma Grade 3A automatically
Every clearance here is in the API, with alerts when new ones post.